S 
Siemens Healthineers SHL.DE · EUR
Health Care · Health Care Equipment & Supplies · XETRA · 🇩🇪 Germany
DAX
43.16
-3.36%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in EUR, from our data supplier.
Revenue
€23.38bn
FY2016FY2025
Net income
€2.14bn
FY2016FY2025
Free cash flow
€2.27bn
FY2016FY2025
Shareholders' equity
€18.04bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €23.38bn | €22.36bn | €21.68bn | €21.71bn | €18.00bn | €14.46bn | €14.52bn | €13.43bn | €13.68bn | €13.55bn |
| Gross profit | €9.03bn | €8.47bn | €7.71bn | €8.14bn | €6.95bn | €5.58bn | €5.80bn | €5.47bn | €5.70bn | €5.47bn |
| Research and development | €1.96bn | €1.92bn | €1.87bn | €1.78bn | €1.55bn | €1.34bn | €1.33bn | €1.28bn | €1.25bn | €1.15bn |
| Operating income | €3.44bn | €3.30bn | €2.44bn | €3.06bn | €2.78bn | €2.04bn | €2.31bn | €2.03bn | €2.22bn | €2.12bn |
| Net income | €2.14bn | €1.94bn | €1.51bn | €2.04bn | €1.73bn | €1.41bn | €1.57bn | €1.26bn | €1.38bn | €1.31bn |
| Diluted earnings per share | 1.91 | 1.72 | 1.33 | 1.82 | 1.52 | 1.31 | 1.56 | 1.26 | 1.39 | 1.31 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | €44.37bn | €46.05bn | €46.68bn | €49.06bn | €41.93bn | €25.09bn | €21.43bn | €19.76bn | €21.11bn | €20.30bn |
| Cash and short-term investments | €2.17bn | €2.68bn | €1.77bn | €1.60bn | €1.32bn | €656.0m | €948.0m | €546.0m | €195.0m | €223.0m |
| Total liabilities | €26.28bn | €27.81bn | €28.55bn | €29.20bn | €25.87bn | €12.58bn | €11.65bn | €11.08bn | €17.82bn | €17.89bn |
| Debt | €14.80bn | €16.23bn | €16.66bn | €16.66bn | €14.32bn | €5.51bn | €4.54bn | €4.71bn | €11.03bn | €11.53bn |
| Shareholders' equity | €18.04bn | €18.20bn | €18.08bn | €19.84bn | €16.04bn | €12.50bn | €9.77bn | €8.66bn | €3.28bn | €2.37bn |
| Shares outstanding | 1,123m | 1,129m | 1,134m | 1,119m | 1,137m | 1,080m | 1,003m | 1,003m | 990m | 1,000m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | €3.08bn | €2.47bn | €2.12bn | €2.50bn | €2.93bn | €1.93bn | €1.50bn | €1.44bn | €1.73bn | €1.67bn |
| Capital spending | −€818.0m | −€696.0m | −€838.0m | −€852.0m | −€674.0m | −€557.0m | −€579.0m | −€530.0m | −€466.0m | −€424.0m |
| Free cash flow | €2.27bn | €1.77bn | €1.28bn | €1.65bn | €2.26bn | €1.37bn | €919.0m | €910.0m | €1.26bn | €1.25bn |
| Dividends paid | −€1.07bn | −€1.06bn | −€1.07bn | −€955.0m | −€856.0m | −€798.0m | −€699.0m | −€230.0m | −€352.0m | −€377.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | €5.76bn | €5.68bn | €5.40bn | €6.32bn | €5.66bn | €5.91bn | €5.48bn | €6.33bn |
| Gross profit | €2.45bn | €2.14bn | €2.08bn | €2.37bn | €2.18bn | €2.32bn | €2.15bn | €2.41bn |
| Operating income | €1.02bn | €755.0m | €724.0m | €938.0m | €872.0m | €895.0m | €731.0m | €986.0m |
| Net income | €669.0m | €506.0m | €450.0m | €588.0m | €552.0m | €530.0m | €474.0m | €616.0m |
| Diluted earnings per share | 0.60 | 0.45 | 0.40 | 0.52 | 0.49 | 0.47 | 0.42 | 0.55 |
| Cash from operations | €1.18bn | €456.0m | €465.0m | €930.0m | €957.0m | €262.0m | €934.0m | €1.24bn |
| Capital spending | −€210.0m | −€183.0m | −€161.0m | −€261.0m | −€192.0m | −€195.0m | −€170.0m | −€213.0m |
| Free cash flow | €969.0m | €273.0m | €304.0m | €669.0m | €765.0m | €67.0m | €764.0m | €1.03bn |
| Total assets | €45.74bn | €44.81bn | €44.27bn | €44.37bn | €44.60bn | €46.91bn | €48.32bn | €46.05bn |
| Cash and short-term investments | €2.36bn | €1.91bn | €2.14bn | €2.17bn | €2.37bn | €2.40bn | €2.77bn | €2.68bn |
| Debt | €3.51bn | €3.90bn | €14.67bn | €15.06bn | €15.70bn | €16.86bn | €16.62bn | €16.21bn |
| Shareholders' equity | €19.10bn | €18.21bn | €18.43bn | €18.04bn | €17.68bn | €18.67bn | €19.78bn | €18.20bn |
Financial ratios
Data as of 19 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 38.6% | 37.9% | 35.6% | 37.5% | 38.6% | 38.6% |
| Operating margin | 14.1% | 14.8% | 11.3% | 14.1% | 15.4% | 14.1% |
| Net margin | 9.2% | 8.7% | 7.0% | 9.4% | 9.6% | 9.8% |
| Return on equity | 11.9% | 10.7% | 8.3% | 10.3% | 10.8% | 11.3% |
| Return on assets | 4.8% | 4.2% | 3.2% | 4.2% | 4.1% | 5.6% |
| Free cash flow yield | 9.2% | 7.4% | 6.9% | 7.9% | 8.4% | 6.1% |
| Revenue growth | 4.5% | 3.2% | -0.2% | 20.7% | 24.5% | -0.4% |
| Earnings growth | 10.4% | 28.7% | -26.0% | 18.0% | 22.4% | -10.0% |
| Current ratio | 1.11x | 1.25x | 1.05x | 1.11x | 1.07x | 1.41x |
| Debt to equity | 0.81x | 0.86x | 0.69x | 0.69x | 0.14x | 0.18x |
| Equity ratio | 40.7% | 39.5% | 38.7% | 40.4% | 38.2% | 49.8% |
| Interest coverage | 7.74x | 6.93x | 8.24x | 25.97x | 33.46x | 26.84x |
| R&D as a share of sales | 8.4% | 8.6% | 8.6% | 8.2% | 8.6% | 9.3% |
| Buybacks as a share of market value | 0.5% | 0.5% | -1.3% | 1.5% | -5.2% | -7.6% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.5% | 10.1% | 6.1% |
| Operating income | 3.9% | 11.0% | 6.1% |
| Net income | 1.7% | 8.7% | 5.3% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 38.3% | 37.4% | 37.7% | 38.7% |
| Operating margin | 14.7% | 13.7% | 14.0% | 14.6% |
| Net margin | 8.9% | 8.6% | 8.9% | 9.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Price to earnings | 23.5 | 29.8 | 39.5 | 25.7 | 43.3 | 32.1 | 27.4 | 29.0 |
| Price to sales | 2.1 | 2.6 | 2.8 | 2.4 | 4.2 | 3.1 | 3.0 | 2.7 |
Dividends and splits
Per share, in the currency the company pays
Paid for 8 years. Last went ex-dividend on 6 Feb 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.00 | 1.93 | 0.95 | 0.95 | 0.85 | 0.80 | 0.80 | 0.302 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.